Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 25,214 shares at $10.52 ($269K) on 2021-08-30, disclosed to the SEC on 2021-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.52 | 8,625 | $91K | 33.7% |
| 2 | $10.70 | 6,000 | $64K | 23.9% |
| 3 | $10.70 | 6,000 | $64K | 23.9% |
| 4 | $10.87 | 4,589 | $50K | 18.5% |
| Total | $10.67 avg | 25,214 | $269K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-07 | $274K | — | Filing → |
| LUMO | BUY | 2021-08-27 | $314K | — | Filing → |
| LUMO | BUY | 2021-08-24 | $1.2M | — | Filing → |